EUVIMEDEUVIMED entdecken
Editorial

Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

Zoltan Benyó, Emilio Clementi, Serge Cremers, Beáta Dávid, Tomasz Guzik, Gerd Heusch, Michael Jarvis, Kaan Orhan, Roland Seifert, József Tímár, Zoltan Ungvari, Péter Ferdinandy

British Journal of Pharmacology · 2024-08 · 181 (15) · 2387-2390

DOI: 10.1111/bph.16480 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Pharmacology, online erschienen am 09.06.2024. Verfasst von Zoltan Benyó und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Periodicals as Topic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the academic community has faced a growing threat from predatory journals. These are publications that prioritize profit over quality scholarship and compromise the integrity of scientific discourse. Predatory journals often bypass rigorous peer review processes, creating a platform for substandard and sometimes fraudulent research. The proliferation of such journals not only undermines trust in scientific publications but also poses serious challenges for researchers who are trying to responsibly share their findings. Recognizing these pressing issues, Semmelweis University held a symposium on 16 November 2023, titled 'Science Integrity in the Era of Predator Journals'. This event was a response to growing concerns about academic publishing. It brought together editors in chief (EiCs) from 14 top journals to discuss critical topics. These included using AI to detect publication fraud, the identification of AI-generated papers, combating paper mills, the necessity of robust submission and review processes and the importance of author identity and conflict of interest vetting. This editorial offers a thorough summary of the symposium's discussions. It highlights the collaborative efforts to improve publication standards and reinforce ethical practices in scientific research. Through shared insights and strategies, the participants tackled the complex challenges posed by predatory journals, setting a course for sustained integrity in the dissemination of scientific knowledge. Professor Péter Ferdinandy, the EiC of the British Journal of Pharmacology (BJP) and host of the event, presented how he plans to continue the long tradition of BJP excellence while improving overall publication quality as well as the experience of both authors and editors. In this regard, steps have been taken to simplify the BJP publication guidelines and improve turnaround times at every step of the review and publication process (Papapetropoulos et al., 2023). He also highlighted that BJP editors in partnership with the BJP publisher Wiley are taking aggressive steps to combat publication fraud. These steps have involved the development of an efficient pipeline to handle ethics investigations as well as the retention of a consulting editor dedicated to matters of research integrity. As a result, ethical concerns raised internally or by third parties are dealt with in a much timelier manner with corrective action being rapidly implemented where necessary. The EiC of the British Journal of Clinical Pharmacology (BJCP—a sister journal of BJP also published by Wiley), Professor Serge Cremers, delved into many issues surrounding the maintenance of publication integrity. As the BJCP deals with many clinical studies, a strong emphasis was placed on resolving the inherent conflicts of interest that arise between the economics of drug development and patient well-being that may bias the publication of clinical trial results. The BJCP requires all submissions to strongly adhere to good clinical practice (GCP) guidelines, have internal review board (IRB) approval and disclose the identity of the physician conducting the trial. The BJCP also utilizes AI-powered systems provided by Wiley for the detection of plagiarism, image manipulation and other forms of fraud. However, BJCP still heavily relies on its editors and reviewers to detect fraud and admits that despite all the safeguards in-place, intercepting all forms of deceit is not perfect. The EiC of Pharmacology Research & Perspectives (PR&P—a collaborative Open Access journal of the British Pharmacology Society [BPS], the American Society for Pharmacology and Experimental Therapeutics and Wiley), Michael Jarvis, highlighted ongoing strategic priorities of publishing pharmacological methods, research replication studies and negative research findings and providing a forum for early career researchers. While only in its 11th year, PR&P provides an important, geographically inclusive, venue for publication of scientifically rigorous papers that directly address issues of research reliability (Jarvis et al., 2023). Like BJP and BJCP, all papers and data submitted to PR&P are initially screened using Wiley's AL-powered manuscript integrity system. Professor Tomasz Guzik, the EiC of Cardiovascular Research, introduced the meeting attendees to the concepts of 'Open Science'. This is an initiative that strives to improve the trust and access to scientific knowledge by implementing 'open' processes at every step of the way from data generation and analysis through publication and dissemination. Pillars of this initiative are open data, open access publication, open source software, open evaluation and open educational resources. This model was also avidly supported by the EiC of Oral Radiology, Professor Kaan Orhan, who emphasized the need for detailed methodological reporting as well as raw data and source code sharing. Prof. Guzik highlighted data sharing tools such as GO Fair that aims to make raw data easily accessible to both humans and computers, the preprint servers bioRxiv and medRxiv and repositories such as the UK Biobank as a model for open access big data dissemination. He also tackled the role of AI within the open science model, addressing the good and the bad. The advantages of AI highlighted were manifold including its speed and efficiency, potential to reduce human-led analysis bias, enhanced pattern recognition, improved reproducibility and generation of robust predictive models. The drawbacks discussed included AI output quality control, intellectual property and data privacy issues, the introduction and perpetuation of analysis biases and the erosion of human user critical thinking. Although there are manifold benefits to the 'Open Science' model, the EiC of Pharmacology Research & Perspectives, Dr. Michael Jarvis, highlighted that the ethos is directly fuelling the rise of paper mills, predatory journals and a sidelining of the peer review process that is making it more challenging to identify high quality publications (Jarvis, 2024; Jarvis & Williams, 2016). Professor Roland Seifert, the EiC of the oldest pharmacology journal Naunyn-Schmiedebergs Arch Pharmacol (NSAP) founded in 1873, gave a detailed account of their ongoing war against the fraudulent publications generated by paper mills. Prof. Seifert detailed a three-step approach used by NSAP to identify fake papers which included checking NSAP rejected and withdrawn manuscripts against published literature using text mining tools, comparing the author lists of rejected/withdrawn NSAP submissions with their subsequently published versions in other journals and finally manual verification that the submission is the same if the author lists differed extensively. In this way, NSAP evaluated 2056 papers rejected/withdrawn between 2015 and 2021, finding that 952 were published elsewhere. Eleven of these 952 had radically different author lists than the NSAP submitted versions, and 10 of these were ultimately deemed to be fake papers (Wittau et al., 2024). Notably, the vast majority of the authors on these fake papers were Chinese highlighting paper mills as a geographic problem (Wittau & Seifert, 2024). Disappointingly, the journals that published the 10 fake papers have yet to take substantiative corrective action, highlighting that a massive change is necessary in how journals cooperate to maintain the scientific record. To combat paper mills, NSAP proposes the establishment of a database where all journals would submit their received manuscripts to enable cross-checking and flagging of potentially fraudulent papers. The best way to prevent overt publication fraud is to detect it at its earliest stages. To this end, the EiCs of Pathology Oncology Research (Dr. József Tímár), Physiology International (Dr. Zoltan Benyó), Pharmacological Research (Professor Emilio Clementi) and the European Journal of Mental Health (Professor Dávid Beáta) detailed the criteria they use to screen submissions. Immediate warning signs of potential fraud include all of the authors on a manuscript having 0–2 previous publications, use of non-institutional email addresses, the claimed institute not having an easily identified homepage, study funding undefined yet the submission contains expensive experiments and if the authors cannot suggest potential reviewers for their work. To help validate author identity, it is suggested that ORCIDs as well as work email addresses should be required. At the level of the manuscript itself, plagiarism should be screened for stringently with 0% text overlap occurring in the results section and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Periodicals as TopicScientific MisconductHumansEditorial PoliciesPublishing

Autor:innen und Institutionen

  • Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.
  • HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Budapest, Hungary.
  • Pharmacovigilance & Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università…
  • Scientific Institute, IRCCS E. Medea, Bosisio Parini, Italy.
  • Department of Pathology & Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA.

Zitieren

APA

Benyó, Z., Clementi, E., Cremers, S., Dávid, B., Guzik, T., Heusch, G., Jarvis, M., Orhan, K., Seifert, R., Tímár, J., Ungvari, Z., & Ferdinandy, P. (2024). Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium. British Journal of Pharmacology, 181(15), 2387-2390. https://doi.org/10.1111/bph.16480

Vancouver

Benyó Z, Clementi E, Cremers S, Dávid B, Guzik T, Heusch G, et al. Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium. British Journal of Pharmacology. 2024;181(15):2387-2390. doi:10.1111/bph.16480

BibTeX
@article{Beny2024,
  author = {Benyó, Zoltan and Clementi, Emilio and Cremers, Serge and Dávid, Beáta and Guzik, Tomasz and Heusch, Gerd and Jarvis, Michael and Orhan, Kaan and Seifert, Roland and Tímár, József and Ungvari, Zoltan and Ferdinandy, Péter},
  title = {Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {15},
  pages = {2387--2390},
  doi = {10.1111/bph.16480}
}
Kostenlos starten →